Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B LIVINGSTON

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Cancer|August 1, 1979
Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancerG N Hortobagyi, G R Blumenschein, C K Tashima, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.
British Medical Journal|November 20, 1976
Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCGJ U Gutterman, J O Cardenas, G R Blumenschein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group StudyM S Kies, J G Mira, J J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancerD H Lau, J J Crowley, D R Gandara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant TherapyJ H Schiller, S Adak, R H Feins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2005
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group studyH L West, J J Crowley, R B Vance, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group studyA J Wozniak, J J Crowley, S P Balcerzak, et al.
The Cancer Journal From Scientific American|August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trialP J Hesketh, J J Crowley, H A Burris, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancerC R Thomas, D J Giroux, L M Janaki, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Cancer|August 1, 1979
Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancerG N Hortobagyi, G R Blumenschein, C K Tashima, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.
British Medical Journal|November 20, 1976
Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCGJ U Gutterman, J O Cardenas, G R Blumenschein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group StudyM S Kies, J G Mira, J J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancerD H Lau, J J Crowley, D R Gandara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant TherapyJ H Schiller, S Adak, R H Feins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2005
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group studyH L West, J J Crowley, R B Vance, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group studyA J Wozniak, J J Crowley, S P Balcerzak, et al.
The Cancer Journal From Scientific American|August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trialP J Hesketh, J J Crowley, H A Burris, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancerC R Thomas, D J Giroux, L M Janaki, et al.
Pageof 20